Biomarkers

Measurable indicators of biological state, exposure, or disease. In the metallomics context, biomarkers span three interconnected domains: metal biomarkers (quantifying exposure and body burden), microbiome biomarkers (reflecting microbial community disruption), and metabolite biomarkers (capturing downstream functional consequences). Integrating these layers is the promise of the metallomics approach.

Metal Biomarkers

Blood

- Blood lead level (BLL): Standard for Pb exposure; reflects recent/ongoing exposure (half-life ~30 days in blood). No safe threshold established.
- Blood Hg: Total and speciated (methyl vs. inorganic); reflects recent fish consumption and chronic exposure.
- Serum Zn, Cu, Fe: Reflect circulating levels but are confounded by inflammation (acute-phase responses alter Cu and Fe distribution).
- Ceruloplasmin: Copper-containing acute-phase protein; elevated in inflammation, low in Wilson's disease.

Urine

- Urinary Cd: Reflects long-term body burden (renal accumulation); beta-2 microglobulin co-measurement indicates tubular damage [balali mood 2021 toxic mechanisms five heavy metals].
- Urinary As: Speciation (inorganic vs. organic) distinguishes toxic exposure from dietary arsenobetaine (seafood).
- 8-OHdG: Urinary oxidative DNA damage marker; elevated with As, Cr, Cd exposure.
- Metallophores: Emerging -- microbial siderophores detectable in urine as infection biomarkers [patil 2021 infection metallomics critical care].

Hair and Toenails

- Hair metals: Reflect months of exposure; used in epidemiological studies of Hg (from fish), As, and Pb. Subject to external contamination.
- Toenail metals: Integrate 6-12 months of exposure; less prone to external contamination than hair; used for Se, As, Hg assessment.

Tissue

- Liver Fe (ferritin, MRI): Gold standard for iron overload assessment.
- Bone Pb: K-XRF measurement reflects cumulative lifetime lead exposure (half-life ~20-30 years in bone).

Microbiome Biomarkers

See microbial biomarkers for detailed treatment. Key examples:
- F. prausnitzii depletion: IBD diagnostic and relapse predictor.
- F. nucleatum enrichment: CRC diagnostic and prognostic marker.
- Alpha diversity reduction: Non-specific but consistent marker of dysbiosis across metal exposure and disease states.

Metabolite Biomarkers

- tmao: Plasma levels predict cardiovascular events; reflects gut microbial choline/carnitine metabolism.
- p-Cresol sulfate: Elevated in ASD and CKD; reflects Clostridioides activity in gut.
- calprotectin (fecal): Neutrophil-derived; gold standard for non-invasive IBD monitoring.
- hepcidin: Circulating peptide reflecting iron status and inflammatory state; low in iron deficiency, high in inflammation.
- Fecal SCFAs: Reduced butyrate/propionate reflects loss of fermentative microbiome capacity.
- Indoxyl sulfate: Uremic toxin; microbial indole derivative accumulating in CKD.

Metallomic Signatures

The metallomics approach measures the complete metal profile (ionome) rather than individual metals, revealing patterns invisible to single-metal analysis:
- Multi-metal signatures in pancreatic cancer (urinary Cd, Ni, Co patterns) [akash 2023 metabolomics heavy metal toxicities].
- Hair metal ratios (e.g., Zn/Cu, Fe/Pb) as integrative exposure metrics.
- Serum metallome changes tracking disease progression in Alzheimer's, Parkinson's, and cardiovascular disease.

Challenges

- Specimen timing: Blood reflects acute exposure; urine reflects recent clearance; hair/nails reflect chronic burden. No single specimen captures the full picture.
- Confounders: Inflammation alters metal distribution (hypoferremia, hypercupremia of infection); dietary intake affects both metal and microbiome markers.
- Reference ranges: Vary by population, age, sex, and analytical method; no universal thresholds for most metals.